Bionano Genomics, Inc. — Director's Dealing 2021

Dec 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2021-11-29

Reporting Person: Holmlin R. Erik (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-29	Common Stock	P	2200	$3.985	Acquired	2200	Indirect
2021-11-29	Common Stock	P	2675	$3.99	Acquired	4875	Indirect
2021-11-29	Common Stock	P	150	$3.98	Acquired	5025	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	585191	Direct